文献速递免疫规划

初免途径与首免日龄塑造虹鳟的初免-加强疫苗应答

Priming route and age at first vaccination shape prime and boost vaccine responses in rainbow trout (Oncorhynchus mykiss).
PubMed 文献 · Vaccine · 2026-03-04

本研究评估虹鳟在1000或1500度日(DD)时经鼻内(IN)或浸泡(Imm)初免、28天后经IN、Imm或肌注(IM)加强,针对传染性造血器官坏死病毒(IHNV)减毒活疫苗的免疫效果。初免后5个月以强毒IHNV攻击,结果显示IN/IN组生存率最高(97-98%),但差异仅在1500 DD组显著;血清特异性IgM滴度以IN/IN组最高、Imm/Imm组最低。

要点

  • IN/IN初免-加强组生存率最高(97-98%),但年龄差异仅在1500 DD组显著。
  • 1500 DD虹鳟Imm初免后IM加强的生存率显著高于IN或Imm加强。
  • 血清特异性IgM滴度以IN/IN组最高、Imm/Imm组最低,常与疫苗效力一致。

核心结论

  • 初免途径和首免日龄均是虹鳟初免-加强疫苗效力的重要决定因素。

研究设计与样本

  • 虹鳟在1000或1500度日(DD)时经鼻内(IN)或浸泡(Imm)初免,28天后经IN、Imm或肌注(IM)加强,初免后5个月以强毒IHNV攻击。

主要发现

  • IN/IN初免-加强组生存率最高(97-98%),但差异仅在1500 DD组显著。
  • 1500 DD虹鳟Imm初免后IM加强的生存率显著高于IN和Imm加强。
  • 血清特异性IgM滴度以IN/IN组最高、Imm/Imm组最低,常与疫苗效力一致。
  • IN/IN和Imm/IN组中1000 DD鱼的特异性IgM抗体滴度显著高于1500 DD鱼。

临床怎么用

  • 虹鳟IHNV减毒活疫苗初免-加强方案可优先考虑IN/IN途径,尤其对1500 DD鱼。
  • 1500 DD虹鳟若以Imm初免,加强可考虑IM注射以提升保护效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Infectious Hematopoietic Necrosis Virus (IHNV) is a significant economic threat to salmonid aquaculture worldwide. Understanding the factors that influence vaccine effectiveness is essential for controlling current and future IHN outbreaks. Because long-term protection often requires prime-boost vaccination, optimizing each vaccine dose is critical. This study evaluated the protective efficacy of different homologous prime-boost vaccination regimes in rainbow trout 5 months after primary vaccination using a live attenuated vaccine against IHNV. Rainbow trout (1000 or 1500 degree-days, DD) were primed intranasally (IN) or by immersion (Imm) vaccination, and boosted 28 days later via IN, Imm, or intramuscular injection (IM). Fish were challenged 5 months post-primary vaccination with virulent IHNV (500 PFU/fish for 1000 DD and 1000 PFU/fish for 1500 DD), and survival and specific serum IgM antibody titers were measured. Results show that the IN route consistently provided superior survival against IHNV, with the IN/IN prime-boost group showing the highest survival rates (97-98%) of all vaccine combinations tested, regardless of fish age but differences were only significant in the 1500 DD age group. When 1500 DD trout were prime vaccinated by Imm, boosting by IM injection resulted in significantly higher survival compared to IN and Imm boosters. Specific serum IgM titers were highest in the IN/IN prime-boost group and lowest in the Imm/Imm groups, often mirroring vaccine efficacy. Age-dependent differences in specific humoral immune responses were observed with significantly higher specific IgM antibody titers in 1000 DD compared to 1500 DD fish in the IN/IN and Imm/IN groups. Our study reveals that both priming route and age at first vaccination are important determinants of prime-boost efficacy, providing practical guidance for IHNV vaccination in rainbow trout aquaculture with potential applications to other host-pathogen systems.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Abouismail A, Sapayeva S, Erhardt EB, et al. Priming route and age at first vaccination shape prime and boost vaccine responses in rainbow trout (Oncorhynchus mykiss). Vaccine. 2026. PMID: 41785675. doi:10.1016/j.vaccine.2026.128403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。